Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
No of Months
12
12
12
Operating Income
62.00
38.00
35.00
Less :Inter divisional transfers
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
Net Sales
62.00
38.00
35.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
Employee Cost
11.00
4.00
5.00
Operating Expenses
12.00
7.00
6.00
General and Administration Expenses
-1.00
-1.00
-1.00
Selling and Distribution Expenses
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
Total Expenditure
31.00
17.00
19.00
Operating Profit (PBDIT) excl Other Income
30.00
20.00
15.00
Other Income
1.00
0.00
0.00
Operating Profit (PBDIT)
31.00
21.00
16.00
Interest
1.00
1.00
1.00
Profit before Depriciation and Tax
30.00
20.00
14.00
Depreciation
7.00
4.00
4.00
Profit Before Taxation & Exceptional Items
23.00
15.00
10.00
Exceptional Income / Expenses
0.00
0.00
0.00
Profit Before Tax
23.00
15.00
10.00
Provision for Tax
5.00
4.00
2.00
Profit After Tax
17.00
11.00
7.00
Extraordinary Items
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
Profit Balance B/F
31.00
20.00
13.00
Profit Available for appropriations
48.00
31.00
20.00
Appropriations
48.00
31.00
20.00
Equity Dividend (%)
0.00%
0.00%
0.00%
Earnings Per Share
10.41
6.67
4.30
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 62.90% vs 8.54% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 47.40% vs 34.96% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 4.78% vs -23.92% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 55.99% vs 56.05% in Mar 2025
Compare Profit and Loss Results of Pramodini Medica
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
62.00
0
62.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
62.00
0
62.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
0.00
0
0.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
11.00
0
11.00
0%
Operating Expenses
12.00
0
12.00
0%
General and Administration Expenses
-1.00
0
-1.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
31.00
0
31.00
0%
Operating Profit (PBDIT) excl Other Income
30.00
0.00
30.00
0%
Other Income
1.00
0
1.00
0%
Operating Profit (PBDIT)
31.00
0
31.00
0%
Interest
1.00
0
1.00
0%
Profit before Depriciation and Tax
30.00
0
30.00
0%
Depreciation
7.00
0
7.00
0%
Profit Before Taxation & Exceptional Items
23.00
0
23.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
23.00
0
23.00
0%
Provision for Tax
5.00
0
5.00
0%
Profit After Tax
17.00
0
17.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
31.00
0
31.00
0%
Profit Available for appropriations
48.00
0
48.00
0%
Appropriations
48.00
0
48.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
10.41
0
10.41
0%
Profit And Loss - Net Sales
Net Sales 62.29 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 62.90% vs 8.54% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 30.90 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 47.40% vs 34.96% in Mar 2025
Profit And Loss - Interest
Interest 1.30 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 4.78% vs -23.92% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 17.38 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 55.99% vs 56.05% in Mar 2025






